APO-Metaraminol metaraminol (as tartrate) 10 mg/1 mL solution for injection ampoule

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

metaraminol tartrate, Quantity: 18.976 mg (Equivalent: metaraminol, Qty 10 mg)

Disponible depuis:

Arrotex Pharmaceuticals Pty Ltd

forme pharmaceutique:

Injection, solution

Composition:

Excipient Ingredients: sodium metabisulfite; water for injections; sodium chloride

Mode d'administration:

Intravenous

Unités en paquet:

5

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.,It may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

Descriptif du produit:

Visual Identification: clear colorless solution; Container Type: Ampoule; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Statut de autorisation:

Registered

Date de l'autorisation:

2019-09-26